Rehabilitation and physical activity of patients with lung cancer
Authors:
Líška Dávid 1; Rutkowski Sebastian 2; Lauková Jana 3
Authors place of work:
Katedra telesnej výchovy a športu, Filozofi cká fakulta, Univerzita Mateja Bela, Banská Bystrica, Slovenská repubika
1; Department of Physical Education and Physiotherapy, Opole University of Technology, Poland
2; Slovenská zdravotnícka univerzita v Bratislave, Fakulta zdravotníctva so sídlom v Banskej Bystrici, Slovenská republika
3
Published in the journal:
Klin Onkol 2022; 35(1): 32-37
Category:
Přehledy
doi:
https://doi.org/10.48095/ccko202232
Summary
Background: Lung cancer is one of the most common malignancies in the world. In the industrialized world, the incidence and prevalence of lung cancer are increasing. Environmental influences and genetics play an important role in pathogenesis. A major part of treatment includes rehabilitation. Lung cancer results in impaired physical performance and poor quality of life. Rehabilitation programs contribute to stabilizing the course of the disease and lead to increased self-confidence in patients. An essential part of rehabilitation comprises functional testing of the patient including a 6-minute walk test, chair standing test, standing up and go test, likewise timed walking tests, supplemented by strength and muscle mass assessment. Physical exercise therapy includes aerobic exercise and resistance training. Rehabilitation of lung cancer patients has been shown to improve symptoms of fatigue and improve patients‘ quality of life. Another significant benefit is the improvement of patients‘ functional abilities. Purpose: The main aim of this article was to summarize information on rehabilitation treatment modalities in patients with lung cancer.
Keywords:
lung cancer – Quality of life – Fatigue – exercise – rehabilitation – respiratory rehabilitation
Zdroje
1. Lübbe AS, Riesenberg H, Baysal B et al. Rehabilitation of lung cancer patients. Pneumologie 2008; 62 (8): 502–506. doi: 10.1055/s-2008-1038195.
2. Hao JQ, Nong JY, Zhao D et al. The significance of siglec-15 expression in resectable non-small cell lung cancer. Neoplasma 2020; 67 (6): 1214–1222. doi: 10.4149/ neo_2020_200220N161.
3. Wei CM, Zhao XF, Qiu HB et al. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells. Neoplasma 2020; 67 (4): 802–812. doi: 10.4149/neo_2020_190723N657.
4. Qiu Z, Pan XX, You DY. Lncrna dscam-as1 promotes non-small cell lung cancer progression via regulating mir-577/hmgb1 axis. Neoplasma 2020; 67 (4): 871–879. doi: 10.4149/neo_2020_190826N821.
5. Niazil Z, Garazhian E, Esfandi F et al. Expression analysis of the long non-coding RNA LINC01433 in lung cancer. Klin Onkol 2019; 32 (6): 453–455. doi: 10.14735/amko2019453.
6. Venclíček O. External lung cancer risk factors in non--smokers. Onkologie 2020; 14 (1): 45–46.
7. Bencko V, Appelman C. Chronic stress as a risk factor for the incidence and progression of cancer? Prakt Lék 2019; 99 (1): 18–20.
8. Bílek O, Bohovicová L, Demlová R et al. Non-small cell lung cancer – from immunobiology to immunotherapy. Klin Onkol 2016; 29 (Suppl 4): 78–87.
9. Kadlec B. The role of immunotherapy in the treatment of non-small cell lung cancer. Onkologie 2018; 12 (4): 185–193. doi: 10.36290/xon.2018.034.
10. Svatoň M. Prognostic and predictive markers in non- -small cell lung cancer (NSCLC) – 1st part. Onkologie 2019; 13 (5): 233–236.
11. Bade BC, Thomas DD, Scott JB et al. Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol 2015; 10 (6): 861–871. doi: 10.1097/JTO.0000000000000536.
12. Gajra A, Marr AS, Ganti AK. Management of patients with lung cancer and poor performance status. J Natl Compr Canc Netw 2014; 12 (7): 1015–1025. doi: 10.6004/jnccn.2014.0098.
13. Spruit MA, Janssen PP, Willemsen SCP et al. Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: a pilot study. Lung Cancer 2006; 52 (2): 257–260. doi: 10.1016/j.lungcan.2006.01.003.
14. Mravec B, Dubravicky J, Tibensky M et al. Effect of the nervous system on cancer: analysis of clinical studies. Bratisl Lek Listy 2019; 120 (2): 119–123. doi: 10.4149/BLL_2019_019.
15. Čelko J, Malay M, Mašán J et al. Movement activity and cognitive functions. Zdravotnicke Listy 2020; 8 (2): 28–34.
16. Edbrooke L, Denehy L, Granger CL et al. Home-based rehabilitation in inoperable non-small cell lung cancer-the patient experience. Support Care Cancer 2020; 28 (1): 99–112. doi: 10.1007/s00520-019-04783-4.
17. Laurent H, Galvaing G, Thivat E et al. Effect of an intensive 3-week preoperative home rehabilitation programme in patients with chronic obstructive pulmonary disease eligible for lung cancer surgery: a multicentre randomised controlled trial. BMJ Open 2017; 7 (11): e017307. doi: 10.1136/bmjopen-2017-017307.
18. Chang P-H, Lin C-R, Lee Y-H et al. Exercise experiences in patients with metastatic lung cancer: a qualitative approach. PLoS One 2020; 15 (4): e0230188. doi: 10.1371/journal.pone.0230188.
19. Bayly JL, Lloyd-Williams M. Identifying functional impairment and rehabilitation needs in patients newly diagnosed with inoperable lung cancer: a structured literature review. Support Care Cancer 2016; 24 (5): 2359–2379. doi: 10.1007/s00520-015-3066-1.
20. Salhi B, Huysse W, Van Maele G et al. The effect of radical treatment and rehabilitation on muscle mass and strength: a randomized trial in stages I-III lung cancer patients. Lung Cancer 2014; 84 (1): 56–61. doi: 10.1016/j.lungcan.2014.01.011.
21. Čelko J, Gúth A, Malay M et al. Chronic pain and its influence via exercise. Rehabilitacia 2020; 57 (1): 3–20.
22. Pozo CLP, Morgan MAA, Gray JE. Survivorship issues for patients with lung cancer. Cancer Control 2014; 21 (1): 40–50. doi: 10.1177/107327481402100106.
23. Hung H-Y, Wu L-M, Chen K-P. Determinants of quality of life in lung cancer patients. J Nurs Scholarsh 2018; 50 (3): 257–264. doi: 10.1111/jnu.12376.
24. Wesolowski S, Orlowski TM, Kram M. The 6-min walk test in the functional evaluation of patients with lung cancer qualified for lobectomy. Interact Cardiovasc Thorac Surg 2020; 30 (4): 559–564. doi: 10.1093/icvts/ivz313.
25. Marjanski T, Wnuk D, Bosakowski D et al. Patients who do not reach a distance of 500 m during the 6-min walk test have an increased risk of postoperative complications and prolonged hospital stay after lobectomy. Eur J Cardiothorac Surg 2015; 47 (5): e213–e219. doi: 10.1093/ejcts/ezv049.
26. Hattori K, Matsuda T, Takagi Y et al. Preoperative six--minute walk distance is associated with pneumonia after lung resection. Interact Cardiovasc Thorac Surg 2018; 26 (2): 277–283. doi: 10.1093/icvts/ivx310.
27. Kováčiková Z, Neumannová K, Sarvestan J et al. Sit-to--stand test in fall prediction in elderly adults: what are the options of use in clinical practice? Prakt Lék 2020; 100 (2): 78–82.
28. Cramer L, Hildebrandt B, Kung T et al. Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer. J Am Coll Cardiol 2014; 64 (13): 1310–1319. doi: 10.1016/j.jacc.2014.07.948.
29. Michalicka V, Pohnan R. Brain energetic demands during cognitive activities in relation to aerobic load. Mil Med Sci Lett 2019; 88 (4): 159–165. doi: 10.31482/mmsl.2019.013.
30. Poděbradská R, Baniariová K, Peknik O et al. Use of walk as a motion intervention in practice. Rehabilitacia 2019; 56 (3): 222–229.
31. Novák J. Chirurgie a tělocvik. Prakt Lek 2019; 99 (1): 39–41.
32. Vařeka I, Janura M, Vařeková R. Kineziologie chůze. Rehabil Fyz Lék 2018; 25 (2): 81–86.
33. Pupišová Z, Pupiš M, Pivovarniček P. Effects of swimming performance on a change in blood parameters. J Phys Education Sport 2015; 15 (4): 844–848. doi: 10.7752/jpes.2015.04130.
34. Nazarian J. Cardiopulmonary rehabilitation after treatment for lung cancer. Curr Treat Options Oncol 2004; 5 (1): 75–82. doi: 10.1007/s11864-004-0008-4.
35. Riesenberg H, Lübbe AS. In-patient rehabilitation of lung cancer patients – a prospective study. Support Care Cancer 2010; 18 (7): 877–882. doi: 10.1007/s00520-009-0727-y.
36. Messaggi-Sartor M, Marco E, Martínez-Téllez E et al. Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial. Eur J Phys Rehabil Med 2019; 55 (1): 113–122. doi: 10.23736/S1973-9087.18.05156-0.
37. Rutkowska A, Jastrzebski D, Rutkowski S et al. Exercise training in patients with non-small cell lung cancer during in-hospital chemotherapy treatment: a randomized controled trial. J Cardiopulm Rehabil Prev 2019; 39 (2): 127–133. doi: 10.1097/HCR.0000000000000 410.
38. Havlova M, Neumannova K, Švestkova O et al. Pulmonary rehabilitation as a part of complex therapy in patients with chronic obstructive pulmonary disease – Emphysema phenotype – after bronchoscopic volume reduction. Rehabilitacia 2018; 55 (4): 260–269.
39. Divisi D, Di Francesco C, Di Leonardo G et al. Preoperative pulmonary rehabilitation in patients with lung cancer and chronic obstructive pulmonary disease. Eur J Cardiothorac Surg 2013; 43 (2): 293–296. doi: 10.1093/ejcts/ezs257.
40. Bradley A, Marshall A, Stonehewer L et al. Pulmonary rehabilitation programme for patients undergoing curative lung cancer surgery. Eur J Cardiothorac Surg 2013; 44 (4): e266–e271. doi: 10.1093/ejcts/ezt381.
41. Rivas-Perez H, Nana-Sinkam P. Integrating pulmonary rehabilitation into the multidisciplinary management of lung cancer: a review. Respir Med 2015; 109 (4): 437–442. doi: 10.1016/j.rmed.2015.01.001.
42. Nici L. Preoperative and postoperative pulmonary rehabilitation in lung cancer patients. Thorac Surg Clin 2008; 18 (1): 39–43. doi: 10.1016/j.thorsurg.2007.10.003.
43. Wang H, Liu X, Rice SJ et al. Pulmonary rehabilitation in lung cancer. PM R 2016; 8 (10): 990–996. doi: 10.1016/j.pmrj.2016.03.010.
44. Liu X, Wang Y-Q, Xie J. Effects of breathing exercises on patients with lung cancer. Oncol Nurs Forum 2019; 46 (3): 303–317. doi: 10.1188/19.ONF.303-317.
45. Tarumi S, Yokomise H, Gotoh M et al. Pulmonary rehabilitation during induction chemoradiotherapy for lung cancer improves pulmonary function. J Thorac Cardiovasc Surg 2015; 149 (2): 569–573. doi: 10.1016/j.jtcvs.2014.09.123.
46. Hashmi A, Baciewicz FA, Soubani AO et al. Preoperative pulmonary rehabilitation for marginal-function lung cancer patients. Asian Cardiovasc Thorac Ann 2017; 25 (1): 47–51. doi: 10.1177/0218492316683757.
47. Morano MTAP, Mesquita R, Da Silva GPF et al. Comparison of the effects of pulmonary rehabilitation with chest physical therapy on the levels of fibrinogen and albumin in patients with lung cancer awaiting lung resection: a randomized clinical trial. BMC Pulm Med 2014; 14: 121. doi: 10.1186/1471-2466-14-121.
48. Janssen SMJ, Abbink JJ, Lindeboom R et al. Outcomes of pulmonary rehabilitation after treatment for non-small cell lung cancer stages I to IIIa: an observational study. J Cardiopulm Rehabil Prev 2017; 37 (1): 65–71. doi: 10.1097/HCR.0000000000000227.
49. Paramanandam VS, Dunn V. Exercise for the management of cancer-related fatigue in lung cancer: a systematic review. Eur J Cancer Care (Engl) 2015; 24 (1): 4–14. doi: 10.1111/ecc.12198.
50. Quist M, Sommer MS, Vibe-Petersen J et al. Early initiated postoperative rehabilitation reduces fatigue in patients with operable lung cancer: a randomized trial. Lung Cancer 2018; 126: 125–132. doi: 10.1016/j.lungcan.2018.10.025.
51. Šupínová M, Janiczeková E, Kurčíková E. Quality assessment of patients life in its terminal state of the disease and their relatives. Zdrav Listy 2019; 7 (2): 74–80.
52. Sommer MS, Staerkind MEB, Christensen J et al. Effect of postsurgical rehabilitation programmes in patients operated for lung cancer: a systematic review and meta-analysis. J Rehabil Med 2018; 50 (3): 236–245. doi: 10.2340/16501977-2292.
53. Sekine Y, Chiyo M, Iwata T et al. Perioperative rehabilitation and physiotherapy for lung cancer patients with chronic obstructive pulmonary disease. Jpn J Thorac Cardiovasc Surg 2005; 53 (5): 237–243. doi: 10.1007/s11748-005-0032-8.
54. Templeton R, Greenhalgh D. Preoperative rehabilitation for thoracic surgery. Curr Opin Anaesthesiol 2019; 32 (1): 23–28. doi: 10.1097/ACO.0000000000000668.
55. Granger CL. Physiotherapy management of lung cancer. J Physiother 2016; 62 (2): 60–67. doi: 10.1016/j.jphys.2016.02.010.
56. Steffens D, Beckenkamp PR, Hancock M et al. Preoperative exercise halves the postoperative complication rate in patients with lung cancer: a systematic review of the effect of exercise on complications, length of stay and quality of life in patients with cancer. Br J Sports Med 2018; 52 (5): 344. doi: 10.1136/bjsports-2017-098032.
57. Lai Y, Huang J, Yang M et al. Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial. J Surg Res 2017; 209: 30–36. doi: 10.1016/j.jss.2016.09.033.
58. Meng S, Yang F, Dai F et al. Effect of a high intensive preoperative rehabilitation on the perioperative complications in patients with chronic obstructive pulmonary disease eligible for lung cancer surgery. Zhongguo Fei Ai Za Zhi 2018; 21 (11): 841–848. doi: 10.3779/j.issn.1009-3419.2018.11.06.
59. Benzo R, Wigle D, Novotny P et al. Preoperative pulmonary rehabilitation before lung cancer resection: results from two randomized studies. Lung Cancer 2011; 74 (3): 441–445. doi: 10.1016/j.lungcan.2011.05.011.
60. Licker M, Karenovics W, Diaper J et al. Short-term preoperative high-intensity interval training in patients awaiting lung cancer surgery: a randomized controlled trial. J Thorac Oncol 2017; 12 (2): 323–333. doi: 10.1016/j.jtho.2016.09.125.
61. Sebio Garcia R, Yáñez Brage MI, Giménez Moolhuyzen E et al. Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2016; 23 (3): 486–497. doi: 10.1093/icvts/ivw152.
62. Stigt JA, Uil SM, van Riesen SJH et al. A randomized controlled trial of postthoracotomy pulmonary rehabilitation in patients with resectable lung cancer. J Thorac Oncol 2013; 8 (2): 214–221. doi: 10.1097/JTO.0b013e318279d52a.
63. Jonsson M, Hurtig-Wennlöf A, Ahlsson A et al. In-hospital physiotherapy improves physical activity level after lung cancer surgery: a randomized controlled trial. Physiotherapy 2019; 105 (4): 434–441. doi: 10.1016/j.physio.2018.11.001.
64. Zhang L-L, Wang S-Z, Chen H-L et al. Tai chi exercise for cancer-related fatigue in patients with lung cancer undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manage 2016; 51 (3): 504–511. doi: 10.1016/j.jpainsymman.2015.11.020.
65. Barassi G, Bellomo RG, Di Iulio A et al. Preoperative rehabilitation in lung cancer patients: yoga approach. Adv Exp Med Biol 2018; 1096: 19–29. doi: 10.1007/5584_2018_186.
66. Doğan N, Taşcı S. The effects of acupressure on quality of life and dyspnea in lung cancer: a randomized, controlled trial. Altern Ther Health Med 2020; 26 (1): 49–56.
67. Cheng C-S, Chen L-Y, Ning Z-Y et al. Acupuncture for cancer-related fatigue in lung cancer patients: a randomized, double blind, placebo-controlled pilot trial. Support Care Cancer 2017; 25 (12): 3807–3814. doi: 10.1007/s00520-017-3812-7.
Štítky
Dětská onkologie Chirurgie všeobecná OnkologieČlánek vyšel v časopise
Klinická onkologie
2022 Číslo 1
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Management pacientů s MPN a neobvyklou kombinací genových přestaveb – systematický přehled a kazuistiky
- Management péče o pacientku s karcinomem ovaria a neočekávanou mutací CDH1 – kazuistika
- Neodolpasse je bezpečný přípravek v krátkodobé léčbě bolesti
- Cinitaprid – v Česku nová účinná látka nejen pro léčbu dysmotilitní dyspepsie
Nejčtenější v tomto čísle
- Praktické aspekty terapie CAR-T lymfocyty
- Rehabilitácia a pohybová aktivita u pacientov s rakovinou pľúc
- Přehled nejdůležitějších metod léčby keratocystického odontogenního tumoru
- Podtřída imunoglobulinů IgG4 a s ní související patologické stavy aneb jak účinně imitovat nádorové onemocnění